Effects of Natural Products on Neuromuscular Junction

AKKOL E., ŞEKER KARATOPRAK G., Carpar E., Hussain Y., Khan H., Aschner M.

CURRENT NEUROPHARMACOLOGY, cilt.20, sa.3, ss.594-610, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 20 Sayı: 3
  • Basım Tarihi: 2022
  • Doi Numarası: 10.2174/1570159x19666210924092627
  • Dergi Adı: CURRENT NEUROPHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core, EMBASE, MEDLINE, Psycinfo
  • Sayfa Sayıları: ss.594-610
  • Anahtar Kelimeler: Acetylcholinesterase, lambert-eaton myasthenic syndrome, myasthenia gravis, natural product, neuromuscular junction, NMJ diseases, EATON MYASTHENIC SYNDROME, POTENT ACETYLCHOLINESTERASE INHIBITORS, HUPERZINE-A, ANTICHOLINESTERASE ACTIVITY, CHOLINESTERASE INHIBITOR, EPHEDRINE TREATMENT, CLINICAL-PRACTICE, SKELETAL-MUSCLE, DOUBLE-BLIND, IN-VITRO
  • Gazi Üniversitesi Adresli: Evet

Özet

Neuromuscular junction (NMJ) disorders result from damage, malfunction or absence of one or more key proteins involved in neuromuscular transmission, comprising a wide range of disorders. The most common pathology is antibody-mediated or downregulation of ion channels or receptors, resulting in Lambert-Eaton myasthenic syndrome, myasthenia gravis, and acquired neuromyotonia (Isaac's syndrome), and rarely congenital myasthenic syndromes caused by mutations in NMJ proteins. A wide range of symptomatic treatments, immunomodulating therapies, or immunosuppressive drugs have been used to treat NMJ diseases. Future research must be directed at a better understanding of the pathogenesis of these diseases, and developing novel disease-specific treatments. Numerous secondary metabolites, especially alkaloids isolated from plants, have been used to treat NMJ diseases in traditional and clinical practices. An ethnopharmacological approach has provided leads for identifying new treatments for NMJ diseases. In this review, we performed a literature survey in Pubmed, Science Direct, and Google Scholar to gather information on drug discovery from plant sources for NMJ disease treatments. To date, most research has focused on the effects of herbal remedies on cholinesterase inhibitory and antioxidant activities. This review provides leads for identifying potential new drugs from plant sources for the treatment of NMJ diseases.